ICD 10 for Skin Lesion: L98.9 vs D48.5 Clearly Explained

ICD 10 for Skin Lesion: L98.9 and Related Codes

ICD 10 for Skin Lesion: L98.9 and Related Codes

For an unidentified, nontraumatic cutaneous lesion, the ICD-10-CM code is typically L98.9: unidentified skin and subcutaneous tissue disorder. Use it if the healthcare professional records a skin lesion without providing a more precise diagnosis. A distinct code can be needed for a documented cyst, keratosis, nevus, or tumour.

Determining what the record actually supports is the challenging part. A biopsy order does not prove unclear tumour behaviour, and a changing area does not prove malignancy. This guide clarifies the differences, contrasts similar codes, and demonstrates how to transform the provider’s evaluation into a code selection that can be justified.

Skin lesion ICD-10-CM codes at a glance

Start with the diagnosis in the assessment. Match that diagnosis to its indexed term, then verify the full code and instructions in the Tabular List.

ICD-10-CM codeOfficial descriptionSelection cue
L98.9Disorder of the skin and subcutaneous tissue, unspecifiedNonspecific skin lesion with no established diagnosis.
L98.8Other specified disorders of the skin and subcutaneous tissueSpecified disorder that indexes here.
D23.9Other benign neoplasm of skin, unspecifiedDocumented other benign skin neoplasm with unspecified site.
D48.5Neoplasm of uncertain behavior of skinDocumented uncertain histologic behavior.
D49.2Neoplasm of unspecified behavior of bone, soft tissue, and skinDocumented neoplasm with behavior unspecified.
L57.0Actinic keratosisEstablished actinic keratosis.
L82.0Inflamed seborrheic keratosisEstablished inflammation of seborrheic keratosis.
L82.1Other seborrheic keratosisSeborrheic keratosis classified here.
L72.0Epidermal cystDocumented epidermal cyst.
L72.11Pilar cystDocumented pilar cyst.
L72.3Sebaceous cystDocumented sebaceous cyst.
R21Rash and other nonspecific skin eruptionRash without a more definite diagnosis.
R23.8Other skin changesDocumented skin change that indexes here.
R23.9Unspecified skin changesUnspecified skin change that indexes here.

These are complete codes, but this chart isn’t an exhaustive list. Confirm the documented condition rather than choosing whichever description looks closest.

L98.9 versus L98.8: the evaluation is what matters

L98.9 fits an unidentified lesion

A nontraumatic skin lesion may be evaluated by a healthcare professional without determining its kind. In that case, the interaction might be appropriately described by L98.9.

There are acceptable applications for unspecified coding. To make the assertion appear more particular, don’t substitute it with a diagnostic that the record doesn’t support. Sections I.A.9 and I.B.18 of the Official Guidelines deal with this.

L98.8 needs a particular disease

Other specific illnesses that fall under that category are covered by L98.8. Additional observations, including the colour, diameter, or irregular border of a lesion, do not necessarily indicate a particular illness.

A thorough description of an undetected papule, for instance, does not by itself support moving from L98.9 to L98.8. Following the Alphabetic Index, read the assessment. Ask for clarification if the provider’s intended diagnosis is not obvious.

Lesions that are benign, malignant, unclear, and unidentified

There are multiple code families for benign diagnoses

Not every benign skin lesion has a single code. Melanocytic nevi come under D22, although other benign skin neoplasms may fall under D23. Seborrhoeic keratosis and epidermal cysts are classified differently.

For example, a benign cutaneous tumour of the trunk may map to D23.5, whereas a reported melanocytic nevus of the trunk maps to D22.5. Don’t select D23 just because a lesion isn’t malignant. First, determine the condition.

Certain diagnoses can be made clinically by a provider. Don’t apply a general pathology requirement to all benign lesions.

A confirmed malignancy needs to be classified separately

C43 should be used for established malignant melanoma, while C44 should be used for other malignant skin neoplasms, depending on the locale and histology. A distinct categorisation is assigned to an in situ diagnosis, such as D03 for melanoma in situ or D04 for skin cancer in situ.

These complete-code examples show how the established diagnosis changes selection:

CodeOfficial description
C44.311Basal cell carcinoma of skin of nose
C43.61Malignant melanoma of right upper limb, including shoulder
D04.5Carcinoma in situ of skin of trunk

Actinic keratosis uses L57.0. Its premalignant character doesn’t make it an established skin cancer diagnosis.

D48.5 and D49.2 describe different documentation

When a tumour whose histologic behaviour cannot be categorised as benign or malignant is found in the documentation, D48.5 is used. D49.2 is distinct; a neoplasm is identified in the record, but its behaviour is not described.

In order to prevent any pending biopsy from being automatically given D48.5, this distinction should also be incorporated into any clinical pathology lab medical billing solution. D48.5 is not supported by a pending pathology report, and D49.2 is not supported by the word “skin lesion.” Rather than accepting a differential diagnosis as the final diagnosis, the coder should ask the clinician for clarification if the evaluation is ambiguous.

Documentation supported by the recordCoding direction
Skin lesion without an established typeConsider L98.9.
Skin neoplasm documented; behavior unspecifiedConsider D49.2, subject to site exclusions.
Neoplasm with documented uncertain histologic behaviorConsider D48.5, subject to site exclusions.
Established benign, in situ, or malignant diagnosisUse the appropriate diagnosis, histology, and site classification.

The official Neoplasm Table and Tabular List distinguish behavior categories. Review exclusions carefully for genital skin and the vermilion border of the lip, where a general skin-neoplasm code may not apply.

Site-specific coding without invented laterality

Location matters when the selected code family includes site or laterality options. Compare these examples:

CodeOfficial description
D23.5Other benign neoplasm of skin of trunk
D23.21Other benign neoplasm of skin of right ear and external auricular canal
D23.22Other benign neoplasm of skin of left ear and external auricular canal

By contrast, L98.9 has no right-versus-left extension. You can’t add a digit to represent a documented side. Keep the precise location in the note and select only a valid code.

The same principle applies to a skin lesion on the face: its location alone doesn’t establish a neoplasm, cyst, or cancer. Start with the diagnosis, then select the available site detail.

Uncertain About the Right Code for Your Skin Lesion?

Receive a concentrated analysis of the diagnostic criteria, site, and documentation supporting your chosen code. We can assist you in clarifying any issues before submitting the claim.

Supporting documentation for the code decision

The coder can connect the assessment, examination, procedure, and pathology without making assumptions thanks to a helpful lesion remark. Acquire:

  • The assessment is either the diagnosis made by the clinician or a clear declaration that the lesion is still undetected.
  • Specific location: side, body area, and pertinent subsite.
  • Lesion identity: a uniform label connecting the specimen container, procedural remark, and body map.
  • Size, appearance, and recorded symptoms or alterations are clinical findings.
  • Behaviour and histology: when available, the recognised classification of neoplasms.
  • The process: measurements, lesion count, and technique required for procedure coding.
  • The clinical concern or symptoms that support the service are the cause for treatment.
  • Give each lesion a trace. The coding record should indicate which result corresponds to which lesion if a back specimen and a cheek specimen have different diagnoses. Even when the right diagnosis is linked to the incorrect procedure line, issues can still arise.

“Please clarify the diagnosis assessed for lesion A on the right cheek, including whether a neoplasm is established and its behaviour, if known” is an example of a neutral clarification request. Steer clear of phrasing that encourages the clinician to make a diagnosis that will cost more.

Realistic coding situations

These are not patient records; rather, they are illustrative training instances. Each makes the assumption that the provided evaluation is valid and that the choice is unaffected by further instruction.

1. An unidentified forearm lesion

The evaluation notes “skin lesion, right forearm,” however the nature of lesion is not specified. L98.9 might work. There is no laterality character in this code, so maintain the forearm location in the documentation.

2. An established epidermal cyst

An upper back epidermal cyst is the diagnosis made by the healthcare professional. Instead of using a general lesion code, use L72.0. The separate examination of the billed service is supported by the documented symptoms and procedural information.

3. An unidentified neoplasm

The healthcare professional diagnoses a skin tumour but does not describe how it behaves. After reviewing site exclusions, D49.2 might be applicable. Avoid turning incomplete behavioural data into ambiguous histopathological behaviour.

4. A lesion whose histologic behaviour is unclear

D48.5 may be suitable when pathology and provider documentation verify a cutaneous tumour but are unable to categorise its histologic behaviour as benign or malignant. Before issuing this code, a behavioural health billing company that also serves multispecialty practices should confirm the diagnosis, paperwork, and anatomical site. Verify that the described site is covered by D48.5 and look for any relevant exclusions.

5. A biopsy due to cancer concerns

“Rule out basal cell carcinoma” and an undetected skin lesion are listed in the outpatient evaluation. Reporting confirmed BCC from that disparity is not advised. Choose the lesion or finding that is supported. Using the relevant coding procedure, reconcile conclusive results with provider documentation.

6. Various lesions with various diagnosis

The physician diagnoses inflammatory seborrhoeic keratosis on the back and actinic keratosis on the scalp. Different circumstances are described by L57.0 and L82.0. Assign each diagnosis to the appropriate procedure line and treated lesion.

Typical errors in skin lesion coding

Every time a biopsy is requested, use D48.5. The investigation is explained by the order, which does not prove ambiguous histologic behaviour. Examine the evaluation and its supporting conclusions.

reporting a suspected case of cancer that was verified on an outpatient visit. Code the established diagnosis, signs, or findings supported by the encounter in accordance with Section IV.H of the official guidelines.

D23.9 is used to all noncancerous growths. Different code families may apply to a nevus, cyst, wart, and keratosis. Find out the precise diagnosis.

modifying a diagnostic in order to get past a payer edit. Examine the requirements for coverage and documentation. When necessary, ask for a valid explanation; do not fabricate medical necessity.

submitting a category that is not complete. Claim-ready codes are not described by references like D23.x and C44.x. Make sure you have all the necessary characters.

For each descriptive feature, add a code. When routine redness, texture, or other symptoms are essential to an established condition, don’t automatically classify them separately.

failing to settle specimen disputes. Before connecting a result to a claim line, reconcile any mismatched sites, labels, or diagnoses.

Claims for biopsy and removal require a separate process assessment

The condition is described by the diagnosis code. The service is described by the CPT code. “Skin lesion removal” does not have a universal ICD-10-CM code.

The provider’s actions and documentation determine which procedure to use. The lesion and necessary margins are included in the pertinent measurement for excision services. Additionally, a tangential biopsy and a shave removal must be carefully distinguished from one another; using the same tool does not make the treatments equivalent.

Even if a lesion turns out to be benign, keep the diagnostic concern prominent. Without portraying suspected cancer as proven cancer, the letter should describe the results that led to the research.

Reconcile the final diagnosis

Steer clear of a general requirement that the original lesion diagnosis be retained in every biopsy claim. Section IV for outpatient diagnostic test interpretation.K discusses conclusive diagnoses that can be coded; Section IV.For ambulatory surgery, N discusses conclusive postoperative diagnoses. Use the guidelines for the relevant service and record.

Verify which lesion the report indicates, reconcile contradicting documentation, and, if required, adhere to the proper claim-correction procedure. Don’t assume that every lesion treated will have the same outcome as one specimen.

Coverage is not guarantyd by a proper code

“Billable” indicates that the code is finished and ready for reporting. The service, supporting documentation, relevant payer policy, and additional claim requirements continue to determine coverage.

For instance, when assessing specific benign lesion removals, a Medicare local coverage policy takes into account symptoms, functional impairment, documented trauma, and diagnostic concern. Its requirements don’t apply to all payers; they only apply within the parameters of the applicable policy. Instead than presuming that any benign diagnostic ensures payment, review the relevant policy.

Frequently asked questions

What is the ICD-10-CM code for an unspecified skin lesion?

L98.9 may apply to an unspecified, nontraumatic skin lesion when the provider hasn’t established a more specific diagnosis. Its official description is “Disorder of the skin and subcutaneous tissue, unspecified.”

What is the difference between L98.8 and L98.9?

L98.8 covers other specified disorders that classify there. L98.9 covers an unspecified disorder. A detailed description of a lesion’s appearance alone doesn’t establish a specified disorder for L98.8.

When should D48.5 be used instead of D49.2?

D48.5 describes a skin neoplasm with documented uncertain histologic behavior. D49.2 describes a documented neoplasm whose behavior is unspecified. A pending biopsy alone doesn’t establish D48.5.

What is the ICD-10-CM code for a benign skin lesion?

The code depends on the diagnosis. D23 codes cover other benign skin neoplasms; D22 codes cover melanocytic nevi. Diagnosed cysts and seborrheic keratoses have separate classifications.

What diagnosis code applies when skin biopsy results are pending?

Use the established diagnosis or supported signs and findings for the outpatient encounter. L98.9 may apply to an undiagnosed lesion. Don’t report suspected cancer as confirmed or assume that a pending result establishes D48.5.

Does L98.9 cover skin lesion removal?

L98.9 is a diagnosis code, not a removal procedure code or coverage guarantee. The claim also needs the appropriate procedure code and documentation meeting the applicable payer’s requirements.

Match the code to the documented lesion

L98.9 can accurately represent an unspecified skin lesion. A supported diagnosis of a cyst, keratosis, nevus, or neoplasm changes the coding direction. Confirm the assessment, check the available site detail, resolve documentation conflicts, and link each diagnosis to the correct service.

Give Your Dermatology Claims a Clearer Foundation

Bring your coding, documentation, and medical-necessity questions into one review. Discuss support for biopsy, lesion removal, and dermatology billing workflows.

Compare the code to the lesion that has been documented

An unidentified cutaneous lesion can be appropriately represented as L98.9. The coding direction is altered when a cyst, keratosis, nevus, or tumour is confirmed. Verify the evaluation, review the site details that are available, settle disputes in the paperwork, and connect each diagnosis to the appropriate service.

Provide a More Clear Foundation for Your Dermatology Claims

Combine your questions about medical necessity, paperwork, and code into a single review. Talk about dermatology billing workflows, lesion removal, and biopsy support.

Source

CDC ICD-10-CM files

CMS benign-lesion LCD

AAPC L98.9 reference

Leave a Comment

Your email address will not be published. Required fields are marked *

1:1 Meeting with our Medical Billing Manager (Free)

Meeting Agenda: How Resilient MBS can improve your Revenue in 3-Quick Steps?

Get in Touch

One More Step To Continue

Get Free Consultaion

EXCELLENT
Google star 1Google star 2Google star 3Google star 4Google star 5
Based on 15 reviews
Posted on Google Google
Bonnie Russo profile picture
Bonnie Russo
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Resilient Medical Billing Services has been our absolute saving grace—true knights in shining armor! We came from a well-known billing company that left us drowning—five months in and still no credentialing completed, we were overwhelmed, losing money, and even paying money back. It was a nightmare. Then we found Resilient. From day one, their team took charge with professionalism, clarity, and genuine care. They not only cleaned up the mess we were left with, but completed all our new credentialing in record time. Their communication is phenomenal—they’re responsive, proactive, and always available when we need them. Since working with Resilient, we’ve seen a real shift—not just in profit, but in peace of mind. We feel seen, heard, and fully supported. Choosing them has been one of the best decisions we’ve made for our business. Highly, highly recommend! Bonnie Russo, LCSW Owner/Operator Papillon Health and Wellness Psychotherapy
Posted on Google Google
Jartu Garway profile picture
Jartu Garway
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
I can’t recommend Resilient Medical Billing Services enough! They truly made the process of getting credentialed with Medicaid and some of the top insurance companies in the state fast and smooth. From start to finish, they stayed on top of everything, ensuring there were no delays. Their communication was consistent, keeping me informed throughout the entire process. What sets them apart is their dedication to seeing you succeed. They are incredibly respectful, patient, and thorough when requesting information, always double-checking to ensure everything is correct and in place for approval. Their attention to detail helped eliminate any potential roadblocks during the credentialing process. Another major plus is their pricing structure- there's a one-time charge with no hidden fees,and they do exactly what they say. No Surprises, no fine print,Just reliable Services. I will be recommending them for the rest of my career—this team knows how to get the job done right and efficiently! MIKE WOOD IS THE BEST I HONESTLY FEEL LIKE HE IS FAMILY INSTEAD OF A BUSINESS AFFILIATION!!!!
Posted on Google Google
lashelle melton profile picture
lashelle melton
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Positive Review for Resilient Credentialing and Billing Company I am thrilled to share my experience with Resilient Credentialing and Billing Company, having partnered with them since May 2024 for Melton Telepsychiatry Services. From the very beginning, their professionalism and dedication to our clinic's needs have been evident. The team at Resilient has made the credentialing process seamless and efficient. They possess a deep understanding of the nuances in our industry, which has significantly alleviated the stress typically associated with credentialing and billing. Their prompt communication and willingness to address any questions have provided us with peace of mind, allowing us to focus more on our patients. Additionally, their billing services are exemplary. They have streamlined our billing processes, ensuring timely reimbursements and maintaining an accurate account of our services. This has had a positive impact on our cash flow and overall operational efficiency. Overall, I highly recommend Resilient for any clinic looking for reliable, knowledgeable, and supportive credentialing and billing services. Their commitment to client success truly sets them apart in the industry. Thank you, Resilient, for your outstanding service! Dr. LaShelle Melton DNP, APRN, PMHNP-BC, CCHP
Posted on Google Google
Bakary Marong profile picture
Bakary Marong
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Hello Mike Thank you for your credentialing service and I truly appreciate you especially your commitment, respect and professionalism you have shown me during the entire process. I will highly recommend you to anyone who is interested in credentialing services. Mike, it was truly amazing to work with you. Thank you for helping me get credentialed with both Medicare and private insurances. Bakary Marong
Posted on Google Google
Ivanka Acosta profile picture
Ivanka Acosta
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Resilient MBS is the best for all your medical billing service needs! Being a new business owner, I was looking for a company that could help me become in network with certain medical and vision plans. Not only did resilient MBS do that, but they also answered any questions I had about the process and what to expect. The credentialing specialist Mike was great. He was always quick to respond to my emails and would send me frequent updates. I truly recommend Resilient MBS.
Posted on Google Google
Cynthia Madueke profile picture
Cynthia Madueke
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
I have had a highly positive experience working with the team, particularly Mike. They have provided clear and helpful guidance throughout the credentialing process, addressing all my questions and concerns. I am also looking forward to continuing our collaboration on billing services. The team's expertise and support have been invaluable, and I appreciate their dedication to ensuring a smooth and successful experience.
Posted on Google Google
Kristin Tomczak profile picture
Kristin Tomczak
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Working with Mike Wood through Resilient BBS LLC is making the credentialing process as smooth as possible! Mike has been communicative about the process each step of the way and is readily available whenever I have a question and/or need clarification.
Posted on Google Google
ReklayMe Health and Wellness profile picture
ReklayMe Health and Wellness
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
They have been very helpful and very patient throughout my credentialing process. It is a great company to work with!
Verified by Trustindex
Trustindex verified badge is the Universal Symbol of Trust. Only the greatest companies can get the verified badge who has a review score above 4.5, based on customer reviews over the past 12 months. Read more

One More Step To View Pricing